NetworkNewsBreaks – The Green Organic Dutchman H
Post# of 179
(Total Views: 233)
Posted On: 01/08/2019 5:24:42 PM
NetworkNewsBreaks – The Green Organic Dutchman Holdings Ltd. (TSX: TGOD) (OTC: TGODF) Appoints Two New Directors, Adding Deep Medical and Pharmaceutical Experience to its Board
Cannabis-focused research and development company The Green Organic Dutchman Holdings (TSX: TGOD) (OTCQX: TGODF) today announced appointment of Dr. Caroline MacCallum and Jacques Dessureault to its board of directors. Per the update, Dr. MacCallum is one of the world’s most prominent experts in cannabinoid-based medicine. At the University of British Columbia, she is an internist, complex pain and cannabinoid clinician, researcher and clinical instructor in the Department of Medicine, an adjunct professor in the Faculty of Pharmaceutical Sciences Program and an associate member of the Department of Palliative Care. Dr. MacCallum is also Greenleaf Medical Clinic’s medical director, where she has assessed and developed cannabinoid treatment plans for more than 3,000 patients across Canada. Jacques Dessureault has an extensive pharmaceutical career with significant experience in life sciences, over-the-counter, natural health, and technology industries. He has held multiple leadership positions, including serving in an international role with Novartis as its global marketing division head based in Basel, Switzerland, and domestic senior executive roles as president and general manager of Valeant Pharmaceutical Inc., vice president at Bristol Myer-Squibb and business unit head and general manager at Novartis Canada. At Valeant Pharmaceuticals, Dessureault led all Canadian commercial units including research and development and international manufacturing and technical operations. In addition, he held responsibilities for government relations and business acquisitions, integrations and divestments.
“We are incredibly fortunate to add Dr. MacCallum and Jacques Dessureault to our Board of Directors at such a pivotal time, as we approach production ramp-up and our first commercial sales,” TGOD Chairman of the Board Jeff Scott stated in the news release. “The TGOD Board now consists of independent directors with the exception of our CEO. Both new additions possess valuable skills and extensive experience that will greatly benefit TGOD moving forward.”
Please see full disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer
Cannabis-focused research and development company The Green Organic Dutchman Holdings (TSX: TGOD) (OTCQX: TGODF) today announced appointment of Dr. Caroline MacCallum and Jacques Dessureault to its board of directors. Per the update, Dr. MacCallum is one of the world’s most prominent experts in cannabinoid-based medicine. At the University of British Columbia, she is an internist, complex pain and cannabinoid clinician, researcher and clinical instructor in the Department of Medicine, an adjunct professor in the Faculty of Pharmaceutical Sciences Program and an associate member of the Department of Palliative Care. Dr. MacCallum is also Greenleaf Medical Clinic’s medical director, where she has assessed and developed cannabinoid treatment plans for more than 3,000 patients across Canada. Jacques Dessureault has an extensive pharmaceutical career with significant experience in life sciences, over-the-counter, natural health, and technology industries. He has held multiple leadership positions, including serving in an international role with Novartis as its global marketing division head based in Basel, Switzerland, and domestic senior executive roles as president and general manager of Valeant Pharmaceutical Inc., vice president at Bristol Myer-Squibb and business unit head and general manager at Novartis Canada. At Valeant Pharmaceuticals, Dessureault led all Canadian commercial units including research and development and international manufacturing and technical operations. In addition, he held responsibilities for government relations and business acquisitions, integrations and divestments.
“We are incredibly fortunate to add Dr. MacCallum and Jacques Dessureault to our Board of Directors at such a pivotal time, as we approach production ramp-up and our first commercial sales,” TGOD Chairman of the Board Jeff Scott stated in the news release. “The TGOD Board now consists of independent directors with the exception of our CEO. Both new additions possess valuable skills and extensive experience that will greatly benefit TGOD moving forward.”
Please see full disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer
(0)
(0)